Literature DB >> 25007575

[Preparation and immunogenicity of silk fibroin/chitosan microspheres for DNA vaccine delivery against infectious bursal disease virus].

Yan Liu, Zhiqiang Lv, Cun Zhang, Xingrong Zhu, Tuanyuan Shi, Shi Zhong, Zhiqi Meng.   

Abstract

To evaluate the immunities of biodegradable microsphere as a release delivery system for DNA vaccine against Infectious Bursal Disease Virus, in our study, silk fibroin/chitosan microsphere adjuvant was prepared with a precipitation/coacervation method. Both glutaraldehyde and Na2SO4 solution were used in cross-linking. No immune chicken were intramuscularly inoculated at 14 day-old and boosted 2 weeks later. The results show that glutaraldehyde destroyed the DNA activity of the vaccine whereas Na2SO4 solution did not. Factors of the chitosan concentration 0.5% (pH 5.0), silk fibroin concentration 0.6%, plasmid DNA (500 microg/mL) dissolved in 2% Na2SO4 solution were optimized to produce microsphere, with a loading capacity of 89.14%. The average particle size of SF-CS/pCI-VP2/4/3 microsphere is 1.98 microm, and it can protect the loading DNA vaccine from DNase I digestion. Data from anti IBDV ELISA antibodies in the serum show that immunization activity of the microsphere groups were generally higher than plasmid vaccine group (P < 0.05), and the SF/CS compound microspheres group was better than that of sole CS microsphere group. The developed SF/CS microspheres are a very promising vaccine delivery system.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25007575

Source DB:  PubMed          Journal:  Sheng Wu Gong Cheng Xue Bao        ISSN: 1000-3061


  2 in total

Review 1.  Chitosan/Silk Fibroin Materials for Biomedical Applications-A Review.

Authors:  Anna Tuwalska; Sylwia Grabska-Zielińska; Alina Sionkowska
Journal:  Polymers (Basel)       Date:  2022-03-26       Impact factor: 4.329

Review 2.  Fibroin nanoparticles: a promising drug delivery system.

Authors:  Duy Toan Pham; Waree Tiyaboonchai
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.